Donate

Treatment of Angelman Syndrome Using ASO targeting UBE3A-AS

$461,612 2017

Treatment of Angelman Syndrome Using ASO targeting UBE3A-AS

Scott Dindot, PhD

This program supported further exploration of various ASO candidates for paternal gene activation through antisense technology.

M1801221: 2017-2018